The Maharashtra Food and Drug Administration (FDA) urged the public on Monday (October 6, 2025) to immediately stop the sale and use of a specific batch of the Coldrif syrup, following reports of child deaths in Madhya Pradesh and Rajasthan, allegedly linked to the medicine.
The appeal comes amid growing concerns over an adulterated batch of the syrup.
Continue Reading on The Hindu
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.